People · Operator
Named in public records as an officer, director or promoter · active 2014–2024 · Healthtech, Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Retrieve Medical Holdings, Inc. | — | Healthtech | Seed | $2.3M | $8.1M | 2014 |
| Exxel Pharma, INC. | — | Biotechnology | Pre-Seed | $600K | $2.2M | 2024 |
Soren Mogelsvang at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Soren Mogelsvang on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Guy Yachin | 2 | 4 |
| Mark Rosenberg | 1 | 3 |
| Joerg Klaube | 1 | 3 |
| JERRY SWON | 1 | 3 |
| Arnold Tinter | 1 | 2 |
| Cohava Gelber | 1 | 2 |
| Vered Caplan | 1 | 2 |
| Louis C Rose | 1 | 1 |
| Jason C Pottinger | 1 | 1 |
| Todd C Griffith | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.